We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
9 hedge funds and large institutions have $780K invested in Plus Therapeutics in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 9 → 9 (0)
0% more ownership
Funds ownership: 0.46% → 0.46% (+0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
20% less capital invested
Capital invested by funds: $981K → $780K (-$201K)
Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TSS
Two Sigma Securities
New York
|
+$18.7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.96K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.38K |
Top Sellers
| 1 |
ATPW
Ashton Thomas Private Wealth
Scottsdale,
Arizona
|
-$18.9K |
| 2 |
JP Morgan Chase
New York
|
-$146 |